Wuxi Biologics (Cayman) (HK:2269) has released an update.
WuXi Biologics (Cayman) Inc. has announced its intention to present its 2024 interim results and discuss business operations in conference calls scheduled for August 22, 2024. The company has urged shareholders and potential investors to be cautious and not overly rely on the forward-looking statements contained in the presentation. The full presentation, which includes management’s assumptions and estimates, has been made available in the announcement for equal and timely public access.
For further insights into HK:2269 stock, check out TipRanks’ Stock Analysis page.
